Indications
Therapeutic Asset Ratings
3,186 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Car-Nk Cell
Lymphoma
Bangdong Gong
P1/2
CC
(41)
cd19-car_lenti t cell
Acute Lymphoblastic Leukemia
Bambino Gesù Hospital and Research Institute
P1/2
CC
(41)
cd19-cd34t metabolically programmed car transduced t-cells
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Medical University of South Carolina
P1/2
CC
(41)
cd19-ucart
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
University Hospital Heidelberg
P1/2
CC
(41)
cd19-ucart
Follicular Lymphoma
University Hospital Heidelberg
P1/2
CC
(41)
Cervical Cancer-Specific Car-T Cells
Cervical Cancer
Shenzhen Geno-Immune Medical Institute
P1/2
CC
(41)
Chm-2101 Car-T Cells
Gastric Cancer
Chimeric Therapeutics
P1/2
CC
(41)
CNA3103 (LGR5-targeted, Autologous CAR-T Cells)
Metastatic Malignant Neoplasm In The Colon
Carina Biotech Limited
P1/2
CC
(41)
Crispr_Scd001
Sickle Cell Disease
Mark Walters, MD
P1/2
CC
(41)
Cytokine-Treated Veto Cells
Acute Lymphoblastic Leukemia
M.D. Anderson Cancer Center
P1/2
CC
(41)
Cytokine-Treated Veto Cells
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
M.D. Anderson Cancer Center
P1/2
CC
(41)
Cytokine-Treated Veto Cells
Follicular Lymphoma
M.D. Anderson Cancer Center
P1/2
CC
(41)
Cytokine-Treated Veto Cells
Hodgkins Lymphoma
M.D. Anderson Cancer Center
P1/2
CC
(41)
Cytokine-Treated Veto Cells
Mantle Cell Lymphoma
M.D. Anderson Cancer Center
P1/2
CC
(41)
Dual-Target Antigen-Selected Car-Nk
Cancer
Essen Biotech
P1/2
CC
(41)
Dual-Target Antigen-Selected Car-Nk
Glioblastoma
Essen Biotech
P1/2
CC
(41)
Dual-Target Antigen-Selected Car-Nk
Liver Cancer
Essen Biotech
P1/2
CC
(41)
Dual-Target Car-Nk Cells
HER2 Positive Breast Carcinoma
Beijing Biotech
P1/2
CC
(41)
eb103
Lymphoma
Estrella Biopharma, Inc.
P1/2
CC
(41)
Eb-Duo-Car-Nk-Cea/Gcc
Metastatic Malignant Neoplasm In The Colon
Beijing Biotech
P1/2
CC
(41)
Eb-Select Single-Target Car-Nk Cells
Cancer
Essen Biotech
P1/2
CC
(41)
Eb-Select Single-Target Car-Nk Cells
Glioblastoma
Essen Biotech
P1/2
CC
(41)
Eb-Select Single-Target Car-Nk Cells
Liver Cancer
Essen Biotech
P1/2
CC
(41)
ect204 t cells
Hepatocellular Carcinoma
Eureka Therapeutics Inc.
P1/2
CC
(41)
Ex-Vivo Expanded Γδ T Cell Infusion
Acute Lymphoblastic Leukemia
Chinese PLA General Hospital
P1/2
CC
(41)
Showing 2101 to 2125 of 3,186 assets
Previous
Page 85 of 128
Next